Publicaciones en colaboración con investigadores/as de University Medical Center Utrecht (33)

2026

  1. Asundexian for Secondary Stroke Prevention

    The New England journal of medicine, Vol. 394, Núm. 15, pp. 1467-1479

  2. Rationale, design and baseline characteristics of participants in the OCEANIC-STROKE trial of FXIa inhibition for secondary stroke prevention

    European stroke journal, Vol. 11, Núm. 1

  3. The incidence of early recurrent venous thromboembolism: a systematic review and meta-analysis

    Research and Practice in Thrombosis and Haemostasis, Vol. 10, Núm. 1

  4. Voice recognition as an innovative method to identify and monitor heart failure - a review

    Heart failure reviews, Vol. 31, Núm. 1

2025

  1. A Multidimensional Framework for Data Quality Assessment in Heart Failure: Integrating IEEE 2801-2022 and Fairness Metrics

    Proceedings - 2025 IEEE 25th International Conference on Bioinformatics and Bioengineering, BIBE 2025

  2. Clinical validation of an artificial intelligence-based decision support system for diagnosis and risk stratification of heart failure (STRATIFYHF): a protocol for a prospective, multicentre longitudinal study

    BMJ Open, Vol. 15, Núm. 1

  3. Economic burden of heart failure in Europe: A systematic review of costs and cost-effectiveness

    ESC Heart Failure, Vol. 12, Núm. 6, pp. 4055-4068

  4. Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study

    The Lancet Infectious Diseases, Vol. 25, Núm. 11, pp. 1177-1188

2024

  1. Addressing residual risk beyond statin therapy: New targets in the management of dyslipidaemias–A report from the European Society of Cardiology Cardiovascular Round Table

    Journal of Clinical Lipidology, Vol. 18, Núm. 5, pp. e685-e700

  2. Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study

    Journal of Cystic Fibrosis, Vol. 23, Núm. 5, pp. 815-822

  3. Occupational Exposures, Chronic Obstructive Pulmonary Disease and Tomographic Findings in the Spanish Population

    Toxics, Vol. 12, Núm. 10

  4. Outpatient management of cancer-associated pulmonary embolism: A post-hoc analysis from the HOME-PE trial

    Thrombosis Research, Vol. 235, pp. 79-87

  5. Safety of treating acute pulmonary embolism at home: an individual patient data meta-analysis

    European Heart Journal, Vol. 45, Núm. 32, pp. 2933-2950

  6. The IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT): multicenter pig study on the effect of ischemic preconditioning

    Basic Research in Cardiology, Vol. 119, Núm. 6, pp. 893-909

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  3. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

2022

  1. Association of obesity with 3-month mortality in kidney failure patients with COVID-19

    Clinical Kidney Journal, Vol. 15, Núm. 7, pp. 1348-1360

  2. Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study

    Intensive Care Medicine, Vol. 48, Núm. 6, pp. 690-705

  3. Correction to: Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study (Intensive Care Medicine, (2022), 48, 6, (690-705), 10.1007/s00134-022-06705-1)

    Intensive Care Medicine